Metropolitan Life Insurance CO Kal Vista Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $3,539 - $5,720	467 Added 34.52%	1,820 $22,000
Q1 2023 May 15, 2023	SELL	$6.3 - $8.39 $1,146 - $1,526	-182 Reduced 11.86%	1,353 $10,000
Q4 2022 Jun 14, 2023	BUY	$4.2 - $14.24 $764 - $2,591	182 Added 13.45%	1,535 $10.4 Million
Q4 2022 Mar 30, 2023	BUY	$4.2 - $14.24 $676 - $2,292	161 Added 11.72%	1,535 $10,000
Q4 2022 Feb 15, 2023	BUY	$4.2 - $14.24 $676 - $2,292	161 Added 11.72%	1,535 $10,000
Q3 2022 Jun 14, 2023	BUY	$9.85 - $16.83 $206 - $353	21 Added 1.55%	1,374 $19.9 Million
Q2 2022 Jun 20, 2023	BUY	$8.16 - $15.1 $171 - $317	21 Added 1.55%	1,374 $13,000
Q1 2022 Jun 20, 2023	BUY	$11.2 - $16.97 $235 - $356	21 Added 1.55%	1,374 $20,000
Q1 2022 Mar 30, 2023	SELL	$11.2 - $16.97 $43,680 - $66,183	-3,900 Reduced 73.95%	1,374 $20,000
Q1 2022 May 12, 2022	SELL	$11.2 - $16.97 $43,680 - $66,183	-3,900 Reduced 73.95%	1,374 $20,000
Q4 2021 Jun 21, 2023	BUY	$12.36 - $18.28 $48,463 - $71,675	3,921 Added 289.8%	5,274 $69,000
Q3 2021 Jun 21, 2023	BUY	$17.11 - $24.49 $67,088 - $96,025	3,921 Added 289.8%	5,274 $92,000
Q3 2021 Mar 30, 2023	BUY	$17.11 - $24.49 $4,037 - $5,779	236 Added 4.68%	5,274 $92,000
Q3 2021 Nov 15, 2021	BUY	$17.11 - $24.49 $4,037 - $5,779	236 Added 4.68%	5,274 $92,000
Q2 2021 Jun 21, 2023	BUY	$23.12 - $29.91 $85,197 - $110,218	3,685 Added 272.36%	5,038 $120,000
Q2 2021 Aug 16, 2021	BUY	$23.12 - $29.91 $116,362 - $150,537	5,033 Added 100660.0%	5,038 $121,000
Q1 2021 Jun 26, 2023	BUY	$14.69 - $42.57 $54,132 - $156,870	3,685 Added 272.36%	5,038 $129 Million
Q1 2021 Mar 30, 2023	BUY	$14.69 - $42.57 $1,527 - $4,427	104 Added 2.11%	5,038 $129,000
Q1 2021 May 14, 2021	SELL	$14.69 - $42.57 $72,407 - $209,827	-4,929 Reduced 99.9%	5 $129,000
Q4 2020 Jun 22, 2023	BUY	$12.88 - $19.47 $46,123 - $69,722	3,581 Added 264.67%	4,934 $93,000
Q4 2020 Mar 30, 2023	BUY	$12.88 - $19.47 $43,779 - $66,178	3,399 Added 221.43%	4,934 $93,000
Q4 2020 Feb 16, 2021	BUY	$12.88 - $19.47 $63,549 - $96,064	4,934 New	4,934 $94,000
Q2 2019 Jul 12, 2023	SELL	$18.44 - $30.89 $6,656 - $11,151	-361 Reduced 26.68%	992 $22 Million

Others Institutions Holding KALV

# of Institutions

125

Shares Held

47.8M

Call Options Held

551K

Put Options Held

110K

Vr Adviser, LLC New York, NY

6.25M
Shares

$56 Million
7.5% of portfolio
Tang Capital Management LLC San Diego, CA

4.32M
Shares

$38.7 Million
4.26% of portfolio
Suvretta Capital Management, LLC New York, NY

4.21M
Shares

$37.7 Million
1.92% of portfolio
Vestal Point Capital, LP New York, NY

4M
Shares

$35.8 Million
3.51% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.69M
Shares

$33 Million
2.3% of portfolio

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account